Premarket Approval (PMA) is a stringent regulatory process that the U.S. Food and Drug Administration requires for evaluating the safety and effectiveness of high-risk medical devices before they can be marketed. Unlike the 510(k) process, PMA demands substantial scientific evidence to ensure that a new device is safe for widespread use in the public health sector.